Alnylam Pharmaceuticals has seen its Fair Value Estimate rise from $467.94 to $480.17, reflecting a modestly stronger outlook supported by recent analyst enthusiasm. This updated assessment comes ...

Liquidators for the delisted China Evergrande Group have asked "selected bidders" to submit their offers by the end of the month for a property management unit they have been seeking to sell, ...